Casting Swords on Wugong Mountain: The Six Meridians Usher in a New Era | Zhengqing Group’s 2026 Mid-Year Marketing Conference Concludes Successfully
Category:
Release time:
2026-07-16
From July 12 to 15, 2026, the Zhengqing Group’s 2026 Mid-Year Marketing Conference, themed “Forging Swords on Wugong Mountain—Six Veins Usher in a New Era,” was successfully held at the Junlan Hot Spring Hotel on Wugong Mountain in Jiangxi Province. More than 300 frontline marketing professionals and representatives from functional departments gathered on Wugong Mountain for four days of comprehensive sessions to review first-half performance, analyze emerging industry trends, and unveil the full “Six Veins Divine Sword” operational framework for the second half of the year, aligning thinking and setting clear direction for the market‑driving phase ahead.
Industry Outlook Ushers in a New Chapter
Compliance lays a solid foundation for sustainable development.
On the evening of July 12, the conference officially kicked off. Industry expert Duan Jidong delivered a special training session on current pharmaceutical regulatory policies, compliance requirements for academic promotion, and the opportunities and challenges facing the industry. Meanwhile, Group Chairman Wu Feichi, drawing on the company’s year-long transformation roadmap, provided a comprehensive overview of the “Six‑Pulse Divine Sword” strategic framework, establishing Compliance Core Base—Zhujiji Jian·Zhengqingyun—as its cornerstone, while simultaneously advancing initiatives such as the “Thousand Counties, Ten Thousand Towns” program, joint departmental development, the Wangdao model, and a chain of renowned physicians, ultimately aiming to achieve an overarching vision of a pain‑free future.
On the morning of July 13, the focus was on digital transformation in compliance. Heads of various business units sequentially presented their strategies for marketing‑compliance transformation, CSO‑driven standardized operations, the Zhengqing Cloud digital platform, and the comprehensive implementation guidelines for pharmaceutical representative registration. The meeting also featured a special presentation by Fan Huafeng, President of Jundao Company, who shared insights on corporate compliance transformation. Meanwhile, the eight regional divisions of Zhengqing Fengtongning held closed‑door workshops, developing tailored compliance‑execution plans based on the specific market conditions of each region.
That afternoon, a review was conducted around the “Pioneering Sword: Thousand Counties, Ten Thousand Towns” initiative, summarizing exemplary cases of grassroots demonstration site development from the first half of the year and facilitating regional discussions on implementation strategies for developing grassroots hospitals in the second half. In the evening, the focus shifted to the “Vanguard Sword: Department Co‑construction,” with the launch of an upgraded “Five‑One Project” plan, a report on the year’s academic achievements, a briefing on the “A World Without Toxins” campaign, and the sharing of benchmark collaboration cases with graded hospitals, alongside a workshop on regional implementation plans. Simultaneously, a special sub‑session on academic outreach clinics was held, clarifying a standardized framework for conducting academic activities under the new policies.
That evening, multiple parallel sub‑venues were simultaneously launched across several departments: the Specialty Sales Control Department conducted training on the Lingzhi product line and a roadshow of sales‑driving case studies; the General Distributor Products Department reviewed performance in the North and South regions and refined strategies for attracting partners and maintaining pricing stability; meanwhile, the Haohai Project Department held a dedicated workshop focused on the iterative upgrade of the “Pain-Free World” platform, while each business segment concurrently mapped out growth pathways for the second half of the year.
Pan-Regional Deployment Expands the Track
Mid-term summary and commendation; issuance of攻坚 targets.
On the morning of July 14, we will provide a focused briefing on our three core business lines: the “Zhulu Sword – Royal Path” model, the “Holy Hand Sword – Renowned Physician Chain,” and the “Great Dao Sword – Pain-Free World.” We will detail strategies for expanding into the private‑sector market, building chain‑style clinics, and upgrading our comprehensive pain‑management and health‑care services. Regional teams will engage in on-site discussions to refine implementation plans, review the outcomes of our new‑retail online operations, and integrate our online and offline service networks.
That afternoon, a company-wide meeting was held, during which representatives from the eight major regions and partner affiliates took to the stage one by one to present their regional implementation plans for the “Six Veins Divine Sword” initiative. The meeting also unveiled the 4x5 marketing control system, the supervisory management mechanism, and the plan for building a high‑performing marketing team. Meanwhile, the Marketing Center conducted a comprehensive review of its first‑half performance, identifying key strengths and areas for improvement, and set clear core performance targets for the second half of the year.
A ceremony was held on-site to honor outstanding teams and exemplary individuals for the first half of 2026; the results of the two-day, three-night team‑vs‑team competition were announced; and each business unit took to the stage to solemnly pledge their commitment, with resounding slogans and soaring morale, fully demonstrating the iron‑clad resolve of the entire workforce to sprint toward the second-half objectives.
At the conclusion of the meeting, Group Vice President Wu Tianhao provided guidance to all marketing personnel on upgrading, transforming, and ensuring compliant operations, while Chairman Wu Feichi delivered a closing address, charting the course for the entire marketing team’s transformation and strategic direction.
At the gala, General Manager Xiang and General Manager Wang Dao delivered impassioned performances, while Chairman Wu Feichi took center stage to present a special themed stage production titled “Affection Fills the Dong Homeland, A World Without Pain.” Through an immersive performance, the show conveyed the company’s original aspiration and mission—to deeply cultivate the pain‑management health industry and remain rooted in local communities—vividly articulating the long‑term vision of “A World Without Pain” and infusing the entire evening with heartfelt warmth and brand spirit.
Climbing mountains and honing troops to forge unity.
All six meridians surge forward to sprint toward the year-end target.
On July 15, all participants headed to Wugong Mountain for a team-building activity featuring a collaborative mountain-climbing excursion, honing the iron‑willed spirit of teamwork and resilience in the face of challenges.
In the first half of 2026, with tightening pharmaceutical industry policies and intensifying market competition, all members of the Zhengqing marketing team braved dual pressures, enabling many outstanding professionals to successfully meet their semi‑annual targets. In the second half, the entire Zhengqing marketing force will remain steadfast in upholding compliance as the cornerstone of development, fully implementing the “Six‑Pulse Divine Sword” strategic plan, seizing market opportunities, uniting as one to break through headwinds, and going all out to sprint toward the year’s business objectives. At the same time, we will continue to deepen our commitment to the traditional Chinese medicine industry, staying true to our corporate vision of “A World Without Pain.”